Matches in SemOpenAlex for { <https://semopenalex.org/work/W1975943670> ?p ?o ?g. }
- W1975943670 endingPage "245" @default.
- W1975943670 startingPage "225" @default.
- W1975943670 abstract "High rates of inherent primary resistance to the humanized monoclonal antibody trastuzumab (Herceptin) are frequent among HER2 gene-amplified breast carcinomas in both metastatic and adjuvant settings. The clinical efficacy of trastuzumab is highly correlated with its ability to specifically and efficiently target HER2-driven populations of breast cancer stem cells (CSCs). Intriguingly, many of the possible mechanisms by which cancer cells escape trastuzumab involve many of the same biomarkers that have been implicated in the biology of CS-like tumor-initiating cells. In the traditional, one-way hierarchy of CSCs in which all cancer cells descend from special self-renewing CSCs, HER2-positive CSCs can occur solely by self-renewal. Therefore, by targeting CSC self-renewal and resistance, trastuzumab is expected to induce tumor shrinkage and further reduce breast cancer recurrence rates when used alongside traditional therapies. In a new, alternate model, more differentiated non-stem cancer cells can revert to trastuzumab-refractory, CS-like cells via the activation of intrinsic or microenvironmental paths-to-stemness, such as the epithelial-to-mesenchymal transition (EMT). Alternatively, stochastic transitions of trastuzumab-responsive CSCs might also give rise to non-CSC cellular states that lack major attributes of CSCs and, therefore, can remain “hidden” from trastuzumab activity. Here, we hypothesize that a better understanding of the CSC/non-CSC social structure within HER2-overexpressing breast carcinomas is critical for trastuzumab-based treatment decisions in the clinic. First, we decipher the biological significance of CSC features and the EMT on the molecular effects and efficacy of trastuzumab in HER2-positive breast cancer cells. Second, we reinterpret the genetic heterogeneity that differentiates trastuzumab-responders from non-responders in terms of CSC cellular states. Finally, we propose that novel predictive approaches aimed at better forecasting early tumor responses to trastuzumab should identify biological determinants that causally underlie the intrinsic flexibility of HER2-positive CSCs to “enter” into or “exit” from trastuzumab-sensitive states. An accurate integration of CSC cellular states and EMT-related biomarkers with the currently available breast cancer molecular taxonomy may significantly improve our ability to make a priori decisions about whether patients belonging to HER2 subtypes differentially enriched with a “mesenchymal transition signature” (e.g., luminal/HER2 vs. basal/HER2) would distinctly benefit from trastuzumab-based therapy ab initio." @default.
- W1975943670 created "2016-06-24" @default.
- W1975943670 creator A5002132146 @default.
- W1975943670 creator A5014700626 @default.
- W1975943670 creator A5017248208 @default.
- W1975943670 creator A5030166947 @default.
- W1975943670 creator A5040427139 @default.
- W1975943670 creator A5077187730 @default.
- W1975943670 creator A5079557997 @default.
- W1975943670 creator A5081859210 @default.
- W1975943670 creator A5086752360 @default.
- W1975943670 creator A5089975001 @default.
- W1975943670 date "2013-01-15" @default.
- W1975943670 modified "2023-10-18" @default.
- W1975943670 title "Basal/HER2 breast carcinomas" @default.
- W1975943670 cites W1226810604 @default.
- W1975943670 cites W1480706413 @default.
- W1975943670 cites W1486455950 @default.
- W1975943670 cites W1548499384 @default.
- W1975943670 cites W1644299043 @default.
- W1975943670 cites W1895627253 @default.
- W1975943670 cites W1965822047 @default.
- W1975943670 cites W1967467247 @default.
- W1975943670 cites W1968863785 @default.
- W1975943670 cites W1969346276 @default.
- W1975943670 cites W1974012180 @default.
- W1975943670 cites W1974295295 @default.
- W1975943670 cites W1976203623 @default.
- W1975943670 cites W1982437692 @default.
- W1975943670 cites W1982878657 @default.
- W1975943670 cites W1987269847 @default.
- W1975943670 cites W1989696946 @default.
- W1975943670 cites W1991953785 @default.
- W1975943670 cites W1994015824 @default.
- W1975943670 cites W1994915667 @default.
- W1975943670 cites W1996494247 @default.
- W1975943670 cites W1997280228 @default.
- W1975943670 cites W1999519607 @default.
- W1975943670 cites W2000092807 @default.
- W1975943670 cites W2002654154 @default.
- W1975943670 cites W2003149480 @default.
- W1975943670 cites W2003934359 @default.
- W1975943670 cites W2004471993 @default.
- W1975943670 cites W2006174435 @default.
- W1975943670 cites W2007750854 @default.
- W1975943670 cites W2008202172 @default.
- W1975943670 cites W2009218955 @default.
- W1975943670 cites W2010672807 @default.
- W1975943670 cites W2012117840 @default.
- W1975943670 cites W2013720404 @default.
- W1975943670 cites W2014194530 @default.
- W1975943670 cites W2015617213 @default.
- W1975943670 cites W2015947790 @default.
- W1975943670 cites W2020372547 @default.
- W1975943670 cites W2021757510 @default.
- W1975943670 cites W2023316892 @default.
- W1975943670 cites W2023427658 @default.
- W1975943670 cites W2023507218 @default.
- W1975943670 cites W2025728074 @default.
- W1975943670 cites W2025823278 @default.
- W1975943670 cites W2026386895 @default.
- W1975943670 cites W2027701773 @default.
- W1975943670 cites W2028236537 @default.
- W1975943670 cites W2028593825 @default.
- W1975943670 cites W2029532166 @default.
- W1975943670 cites W2031569617 @default.
- W1975943670 cites W2031770999 @default.
- W1975943670 cites W2035880310 @default.
- W1975943670 cites W2039460279 @default.
- W1975943670 cites W2040524130 @default.
- W1975943670 cites W2041263494 @default.
- W1975943670 cites W2041777830 @default.
- W1975943670 cites W2043376395 @default.
- W1975943670 cites W2043620899 @default.
- W1975943670 cites W2044224053 @default.
- W1975943670 cites W2044461696 @default.
- W1975943670 cites W2045041589 @default.
- W1975943670 cites W2045909049 @default.
- W1975943670 cites W2051204314 @default.
- W1975943670 cites W2054030645 @default.
- W1975943670 cites W2055498399 @default.
- W1975943670 cites W2056054628 @default.
- W1975943670 cites W2057139536 @default.
- W1975943670 cites W2059752332 @default.
- W1975943670 cites W2060654974 @default.
- W1975943670 cites W2061301308 @default.
- W1975943670 cites W2064176617 @default.
- W1975943670 cites W2064214794 @default.
- W1975943670 cites W2064486198 @default.
- W1975943670 cites W2065666141 @default.
- W1975943670 cites W2068449976 @default.
- W1975943670 cites W2068886353 @default.
- W1975943670 cites W2071290709 @default.
- W1975943670 cites W2072001967 @default.
- W1975943670 cites W2075219223 @default.
- W1975943670 cites W2076900469 @default.
- W1975943670 cites W2077045470 @default.
- W1975943670 cites W2077238012 @default.